Clinical Trial Update: Inebilizumab in Acute Neuromyelitis Optica Spectrum Disorders

View source ↗

Summary

A clinical trial registration indicates ongoing recruitment for Inebilizumab in acute Neuromyelitis Optica Spectrum Disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuromyelitis Optica Spectrum Disorder

Drugs mentioned

• Inebilizumab (inebilizumab)

Snippet

Sponsor: Xuanwu Hospital, Beijing | Conditions: Neuromyelitis Optica Spectrum Disorder | Status: RECRUITING